X Square Capital, LLC Adaptimmune Therapeutics PLC Transaction History
X Square Capital, LLC
- $276 Million
- Q2 2025
A detailed history of X Square Capital, LLC transactions in Adaptimmune Therapeutics PLC stock. As of the latest transaction made, X Square Capital, LLC holds 11,173 shares of ADAP stock, worth $2,011. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,173
Previous 11,173
-0.0%
Holding current value
$2,011
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ADAP
# of Institutions
69Shares Held
116MCall Options Held
10.3KPut Options Held
0-
Eco R1 Capital, LLC San Francisco, CA27.4MShares$4.93 Million0.57% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR23.8MShares$4.28 Million0.26% of portfolio
-
Two Seas Capital LP Rye, NY22.6MShares$4.06 Million0.1% of portfolio
-
Nea Management Company, LLC Timonium, MD17.1MShares$3.07 Million0.34% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.81MShares$865,7412.66% of portfolio
About Adaptimmune Therapeutics PLC
- Ticker ADAP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 163,370,000
- Market Cap $29.4M
- Description
- Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...